These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 35255755)
1. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software. Woo JH; Kim EC; Kim SM Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of regulatory perspectives on innovative medical devices in Korea and the United States. Choe M; Shim JH; Heo CY Expert Rev Med Devices; 2022 Mar; 19(3):229-235. PubMed ID: 35293274 [TBL] [Abstract][Full Text] [Related]
3. Methodology for Conducting Post-Marketing Surveillance of Software as a Medical Device Based on Artificial Intelligence Technologies. Zinchenko VV; Arzamasov KM; Chetverikov SF; Maltsev AV; Novik VP; Akhmad ES; Sharova DE; Andreychenko AE; Vladzymyrskyy AV; Morozov SP Sovrem Tekhnologii Med; 2022; 14(5):15-23. PubMed ID: 37181834 [TBL] [Abstract][Full Text] [Related]
4. Innovation Process and Industrial System of US Food and Drug Administration-Approved Software as a Medical Device: Review and Content Analysis. Yu J; Zhang J; Sengoku S J Med Internet Res; 2023 Nov; 25():e47505. PubMed ID: 37999948 [TBL] [Abstract][Full Text] [Related]
5. Changes in software as a medical device based on artificial intelligence technologies. Zinchenko V; Chetverikov S; Akhmad E; Arzamasov K; Vladzymyrskyy A; Andreychenko A; Morozov S Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1969-1977. PubMed ID: 35691995 [TBL] [Abstract][Full Text] [Related]
6. Editorial: Global Initiatives Support the Use and Regulation of Digital Health Technology During the COVID-19 Pandemic. Parums DV Med Sci Monit; 2021 Oct; 27():e935123. PubMed ID: 34657930 [TBL] [Abstract][Full Text] [Related]
7. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health. Ronquillo JG; Zuckerman DM Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231 [TBL] [Abstract][Full Text] [Related]
8. Regulatory considerations for medical imaging AI/ML devices in the United States: concepts and challenges. Petrick N; Chen W; Delfino JG; Gallas BD; Kang Y; Krainak D; Sahiner B; Samala RK J Med Imaging (Bellingham); 2023 Sep; 10(5):051804. PubMed ID: 37361549 [TBL] [Abstract][Full Text] [Related]
9. AI as a Medical Device Adverse Event Reporting in Regulatory Databases: Protocol for a Systematic Review. Kale AU; Dattani R; Tabansi A; Hogg HDJ; Pearson R; Glocker B; Golder S; Waring J; Liu X; Moore DJ; Denniston AK JMIR Res Protoc; 2024 Jul; 13():e48156. PubMed ID: 38990628 [TBL] [Abstract][Full Text] [Related]
10. Digital Tools-Regulatory Considerations for Application in Clinical Trials. Gelis L; Stoeckert I; Podhaisky HP Ther Innov Regul Sci; 2023 Jul; 57(4):769-782. PubMed ID: 37195515 [TBL] [Abstract][Full Text] [Related]
11. Translating the regulatory landscape of medical devices to create fit-for-purpose artificial intelligence (AI) cytometry solutions. Bogdanoski G; Lucas F; Kern W; Czechowska K Cytometry B Clin Cytom; 2024 Jul; 106(4):294-307. PubMed ID: 38396223 [TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence in medical device software and high-risk medical devices - a review of definitions, expert recommendations and regulatory initiatives. Fraser AG; Biasin E; Bijnens B; Bruining N; Caiani EG; Cobbaert K; Davies RH; Gilbert SH; Hovestadt L; Kamenjasevic E; Kwade Z; McGauran G; O'Connor G; Vasey B; Rademakers FE Expert Rev Med Devices; 2023 Jun; 20(6):467-491. PubMed ID: 37157833 [TBL] [Abstract][Full Text] [Related]
13. Regulatory Framework for Drug-Device Combination Products in the United States, Europe, and Korea. Kim JH; Kwon S; Seol JE; Kim MH; Kim SD Ther Innov Regul Sci; 2024 Sep; 58(5):796-806. PubMed ID: 38717522 [TBL] [Abstract][Full Text] [Related]
14. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use. Zhu S; Gilbert M; Chetty I; Siddiqui F Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651 [TBL] [Abstract][Full Text] [Related]
15. Trends in the Approval and Quality Management of Artificial Intelligence Medical Devices in the Republic of Korea. Lim K; Heo TY; Yun J Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204446 [TBL] [Abstract][Full Text] [Related]
16. Minimum labelling requirements for dermatology artificial intelligence-based Software as Medical Device (SaMD): A consensus statement. Ingvar Å; Oloruntoba A; Sashindranath M; Miller R; Soyer HP; Guitera P; Caccetta T; Shumack S; Abbott L; Arnold C; Lawn C; Button-Sloan A; Janda M; Mar V Australas J Dermatol; 2024 May; 65(3):e21-e29. PubMed ID: 38419186 [TBL] [Abstract][Full Text] [Related]
17. When Medical Devices Have a Mind of Their Own: The Challenges of Regulating Artificial Intelligence. Boubker J Am J Law Med; 2021 Dec; 47(4):427-454. PubMed ID: 35297753 [TBL] [Abstract][Full Text] [Related]
18. The 510(k) Third Party Review Program: Promise and Potential. Miller BJ; Blanks W; Yagi B J Med Syst; 2023 Aug; 47(1):93. PubMed ID: 37642768 [TBL] [Abstract][Full Text] [Related]
19. How the FDA Regulates AI. Harvey HB; Gowda V Acad Radiol; 2020 Jan; 27(1):58-61. PubMed ID: 31818387 [TBL] [Abstract][Full Text] [Related]
20. Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions. Hernandez-Boussard T; Lundgren MP; Shah N J Am Med Inform Assoc; 2021 Jun; 28(6):1353-1355. PubMed ID: 33674865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]